$BCTX is pleased to announce that it has received
Post# of 102785
(Total Views: 156)
Posted On: 09/10/2024 12:38:05 PM
$BCTX is pleased to announce that it has received positive feedback from its Pre-IND meeting with the U.S. Food and Drug Administration (FDA), which is a step forward to opening an IND to conduct a Phase 1/2 study of its personalized off-the-shelf immunotherapy, Bria-PROS+™, in advanced prostate cancer. https://www.globenewswire.com/news-release/20...ancer.html
(0)
(0)